Natalizumab. Treatment of IBD, Treatment of multiple sclerosis

被引：5

作者：

Sorbera, LA ^{[1
]}

Martin, L ^{[1
]}

Rabasseda, X ^{[1
]}

机构：

[1] Prous Sci, Barcelona 08080, Spain

来源：

DRUGS OF THE FUTURE | 2000年 / 25卷 / 09期

关键词：

immunoglobulin G 4 (human-mouse monoclonal AN100226 gamma-chain anti-human integrin 4); disulfide with human-mouse; monoclonal AN100226 light chain; dimer;

D O I：

10.1358/dof.2000.025.09.593332

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

[No abstract available]

引用

页码：917 / 921

页数：5

共 28 条

[1]

CARTER JL, 2000, NEUROLOGY S3, V54

[2] MONOCLONAL-ANTIBODIES TO THE INTEGRIN ALPHA-4 SUBUNIT INHIBIT THE MURINE CONTACT HYPERSENSITIVITY RESPONSE [J].

CHISHOLM, PL ;

WILLIAMS, CA ;

LOBB, RR .

EUROPEAN JOURNAL OF IMMUNOLOGY, 1993, 23 (03) :682-688

[3] VCAM-1 ON ACTIVATED ENDOTHELIUM INTERACTS WITH THE LEUKOCYTE INTEGRIN VLA-4 AT A SITE DISTINCT FROM THE VLA-4 FIBRONECTIN BINDING-SITE [J].

ELICES, MJ ;

OSBORN, L ;

TAKADA, Y ;

CROUSE, C ;

LUHOWSKYJ, S ;

HEMLER, ME ;

LOBB, RR .

CELL, 1990, 60 (04) :577-584

[4] Adhesion molecule expression in inflammatory bowel disease (IBD) patients treated with natalizumab (AntegrenTM), a humanised antibody to α4 integrin. [J].

Gordon, FH ;

Rana, S ;

Tahami, F ;

Kosser, K ;

Amlot, PL ;

Pounder, RE .

GASTROENTEROLOGY, 2000, 118 (04) :A344-A344

[5]

GORDON FH, 1999, DIG DIS WEEK 0516

[6]

GORDON FH, 1999, GUT S1, V44

[7] LYMPHOID-CELLS RECOGNIZE AN ALTERNATIVELY SPLICED SEGMENT OF FIBRONECTIN VIA THE INTEGRIN RECEPTOR-ALPHA-4-BETA-1 [J].

GUAN, JL ;

HYNES, RO .

CELL, 1990, 60 (01) :53-61

[8]

HORNER HC, 1995, IBC C ADV UND TREAT

[9]

KARLIC SJ, 1994, IBC 5 ANN C CELL ADH

[10] A MONOCLONAL-ANTIBODY TO ALPHA-4 INTEGRIN SUPPRESSES AND REVERSES ACTIVE EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS [J].

KENT, SJ ;

KARLIK, SJ ;

CANNON, C ;

HINES, DK ;

YEDNOCK, TA ;

FRITZ, LC ;

HORNER, HC .

JOURNAL OF NEUROIMMUNOLOGY, 1995, 58 (01) :1-10

← 1 2 3 →